InvestorsHub Logo
Post# of 316599
Next 10
Followers 364
Posts 113825
Boards Moderated 5
Alias Born 12/28/2000

Re: cintrix post# 315416

Tuesday, 03/21/2023 10:09:18 AM

Tuesday, March 21, 2023 10:09:18 AM

Post# of 316599
ALT A new obesity treatment being developed by Altimmune met goals for weight loss in a mid-stage clinical trial, but the data showed it doesn’t have a leg up on other popular drugs on the market. https://www.statnews.com/2023/03/21/obesity-drug-altimmune-pemvidutide-early-data/

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.